View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200 / Paclitaxel 80 / Carboplatin 1.5, Breast Cancer, neoadjuvant, cycle 1-4
Protocol-ID: 2717 V1.0 (Mini), PEMB200/PACL80/CRBP1.5, Breast Ca, neoadj., C1-4Indication(s)
- Breast Cancer (tripel negative); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 02.10.2024